SuperworthTectonic Therapeutic market cap TECX
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $392.4M
- Highest close in our data
- $1.2B
- Sep 2018
Tectonic Therapeutic is worth $392.4M at the close on Oct 23, 2026, at $20.07 a share.
That is up 22% over the last year and up 60% over five years.
Its highest close in our data was $1.2B in Sep 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $392.4M | $351.9M | $735.6M | +0% |
| 2025 | $390.8M | $280.3M | $798.7M | −44% |
| 2024 | $693.8M | $53.8M | $759.3M | +1045% |
| 2023 | $60.6M | $28.2M | $74.4M | +95% |
| 2022 | $31.1M | $25.4M | $92.5M | −82% |
| 2021 | $168.1M | $156.7M | $623.7M | −67% |
| 2020 | $508.1M | $466.1M | $823M | −18% |
| 2019 | $620.1M | $304.5M | $692.9M | +55% |
| 2018 | $401.3M | $378.7M | $1.2B | n/a |
Against its peers
Companies in Biotechnology nearest Tectonic Therapeutic's size, closest first, today.
| Company | Market cap |
|---|---|
| TECXTectonic Therapeutic | $392.4M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Tectonic Therapeutic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.